Publications by authors named "Michael Blaiss"

Claim this Profile
B
Benefits of Epinephrine for Anaphylaxis Outweigh Potential Harm-A Safety Review.
David I Bernstein, Michael Blaiss, Evan S Dellon, Karen Rance

J Allergy Clin Immunol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based Approach.
Oliver Pfaar, Ralph Mösges, Michael S Blaiss, Sven Becker, Lawrence DuBuske

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Nasal Cavity Dimensions on Frequency of Treatment for Rhinitis Symptoms.
Lirit Levi, Vivek Mohan, Yifei Ma, Christoforos Meliadis, Paramesh Gopi, Michael Blaiss

Int Forum Allergy Rhinol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Bernardo Sousa-Pinto, Jean Bousquet, Rafael José Vieira, Holger J Schünemann, Torsten Zuberbier, Michael S Blaiss

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms.
Jean Bousquet, Bernardo Sousa-Pinto, Rafael José Vieira, Holger J Schünemann, Torsten Zuberbier, Michael S Blaiss

Allergy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review.
Michael Blaiss, Dana Wallace, Joseph K Han, Karen Rance

Allergy Asthma Proc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE).
Jaclyn A Smith, Surinder S Birring, Michael S Blaiss, Lorcan McGarvey, Alyn H Morice

Am J Respir Crit Care Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study.
Eugene Bleecker, Michael Blaiss, Juby Jacob-Nara, Lynn Huynh, Mei Sheng Duh

J Allergy Clin Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults.
Matthew Greenhawt, Jay Lieberman, Michael Blaiss, David I Bernstein, John Oppenheimer

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).
Jean Bousquet, Holger J Schünemann, Bernardo Sousa-Pinto, Torsten Zuberbier, Alkis Togias, Michael S Blaiss

J Allergy Clin Immunol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to diagnose IgE-mediated food allergy.
Jay Lieberman, Antonella Muraro, Michael Blaiss

Arch Dis Child Educ Pract Ed· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degree of fear of needles and preferred allergy immunotherapy treatment among children with allergic rhinitis: caregiver survey results.
Karen Rance, Michael Blaiss, Payel Gupta, Hendrik Nolte, Erin P Scott

Front Pediatr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
Eugene Bleecker, Michael Blaiss, Juby Jacob-Nara, Lynn Huynh, Tracy Guo

Allergy Asthma Proc· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis.
Michael S Blaiss, Stephen R Durham, David Bernstein, Thomas Stranzl, Morten Lindholm

J Allergy Clin Immunol Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Michael Blaiss, Eugene R Bleecker, Juby Jacob-Nara, Radhika Nair, Mei Sheng Duh

Ann Allergy Asthma Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment.
Michael Blaiss, John Oppenheimer, Mark Corbett, Leonard Bacharier, Jonathan Bernstein

Ann Allergy Asthma Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary collaboration in the diagnosis and management of chronic cough: the role and importance of primary care providers.
Peter V Dicpinigaitis, Kenneth W Altman, Isil Ulger Isci, Xuehua Ke, Michael Blaiss

Curr Med Res Opin· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option.
Michael Blaiss, Lawrence DuBuske, Hendrik Nolte, Morten Opstrup, Karen Rance

Front Pediatr· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in the treatment of anaphylaxis: A review of recent data.
Jay A Lieberman, John Oppenheimer, Vivian P Hernandez-Trujillo, Michael S Blaiss

Ann Allergy Asthma Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.
Moisés A Calderon, Thomas B Casale, Harold S Nelson, Leonard B Bacharier, Priya Bansal, Michael Blaiss

J Allergy Clin Immunol Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed solutions by the American College of Allergy, Asthma, and Immunology and advocacy experts to address racial disparities in atopic dermatitis and food allergy.
Mark Corbett, Abby Allen, Nichole Bobo, Michael B Foggs, Luz S Fonacier, Michael S Blaiss

Ann Allergy Asthma Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.
Guy Brusselle, Santiago Quirce, Alberto Papi, Piotr Kuna, Bradley E Chipps, Michael Blaiss

J Allergy Clin Immunol Pract· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Peter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, Lorcan P McGarvey, Alyn H Morice

Ann Allergy Asthma Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric sublingual allergen immunotherapy.
Michael S Blaiss

Allergy Asthma Proc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.
Claus Bachert, Asif H Khan, Claire Hopkins, Michael S Blaiss, Zachary M Soler

J Asthma Allergy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis